Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN for Obesity: Side Effects & Safety Data

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

There are 10 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN was used for Obesity.

Most Reported Side Effects for EMPAGLIFLOZIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 3,644 9.8% 85 2,610
Fungal infection 1,941 5.2% 7 94
Blood glucose increased 1,797 4.9% 4 306
Euglycaemic diabetic ketoacidosis 1,769 4.8% 59 1,340
Weight decreased 1,661 4.5% 25 328
Urinary tract infection 1,439 3.9% 42 687
Ketoacidosis 1,411 3.8% 57 969
Dizziness 1,372 3.7% 13 274
Nausea 1,333 3.6% 20 594
Vomiting 1,201 3.2% 49 769
Acute kidney injury 1,023 2.8% 72 751
Fournier's gangrene 1,000 2.7% 63 681
Diarrhoea 999 2.7% 19 314
Dehydration 973 2.6% 24 581
Pollakiuria 944 2.6% 6 90

Other Indications for EMPAGLIFLOZIN

Product used for unknown indication (16,449) Type 2 diabetes mellitus (12,176) Diabetes mellitus (4,267) Cardiac failure (1,338) Type 1 diabetes mellitus (383) Chronic kidney disease (209) Cardiac failure chronic (172) Cardiac failure congestive (158) Cardiac disorder (157) Blood glucose increased (138)

Other Drugs Used for Obesity

SEMAGLUTIDE (2,586) LIRAGLUTIDE (1,090) BUPROPION\NALTREXONE (726) TIRZEPATIDE (700) ORLISTAT (163) PHENTERMINE (127) DULAGLUTIDE (109) METFORMIN (100) PHENTERMINE\TOPIRAMATE (86) TOPIRAMATE (86)

Related Pages

EMPAGLIFLOZIN Full Profile All Obesity Drugs EMPAGLIFLOZIN Demographics EMPAGLIFLOZIN Timeline